Krystal Biotech Inc (KRYS) — Working Capital to Net Assets Ratio
Krystal Biotech Inc (KRYS) has a Working Capital to Net Assets ratio of 68.6% as of June 2026. Working capital of $932.25 Million (current assets of $1.06 Billion minus current liabilities of $127.40 Million) is measured against net assets of $1.36 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Krystal Biotech Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Krystal Biotech Inc Working Capital to Net Assets (2016–2025)
This chart shows how Krystal Biotech Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 68.6%, reflecting working capital of $932.25 Million against net assets of $1.36 Billion USD. For the complete balance sheet picture, see Krystal Biotech Inc total assets.
Annual Working Capital to Net Assets for Krystal Biotech Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Krystal Biotech Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Krystal Biotech Inc (KRYS) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 75.6% | $921.66 Million | $1.22 Billion | $1.02 Billion | $102.94 Million | ▲ +7.9 pp |
| 2024 | 67.6% | $640.05 Million | $946.38 Million | $742.04 Million | $102.00 Million | ▼ -3.6 pp |
| 2023 | 71.3% | $554.82 Million | $778.64 Million | $587.91 Million | $33.09 Million | ▲ +3.3 pp |
| 2022 | 68.0% | $354.93 Million | $522.23 Million | $383.78 Million | $28.85 Million | ▼ -2.2 pp |
| 2021 | 70.2% | $416.53 Million | $593.58 Million | $442.27 Million | $25.74 Million | ▼ -18.7 pp |
| 2020 | 88.9% | $259.61 Million | $292.08 Million | $275.06 Million | $15.45 Million | ▼ -6.0 pp |
| 2019 | 94.9% | $192.55 Million | $202.91 Million | $195.88 Million | $3.33 Million | ▼ -2.3 pp |
| 2018 | 97.2% | $110.05 Million | $113.23 Million | $112.65 Million | $2.60 Million | ▼ -2.4 pp |
| 2017 | 99.6% | $49.27 Million | $49.47 Million | $49.91 Million | $640.00K | ▼ -636.0 pp |
| 2016 | 735.6% | $2.13 Million | $289.00K | $2.17 Million | $43.00K | — |